Search

everythinglearnresearchcommunity

for

Search:↓

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Chronic inflammation can cause cancer by making stem cells divide and mutate.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Certain genetic variants increase the risk of aggressive prostate cancer.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Cetuximab can cause unusual hair growth and hair loss.

Warts in HIV-positive men can have serious abnormal cell growth, needing careful analysis and treatment to prevent cancer.

Cancer patients in sub-Saharan Africa face significant challenges during chemotherapy, highlighting the need for better patient care and support.

Spironolactone does not increase the risk of breast cancer recurrence.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Patients with chronic kidney disease often have various skin problems that affect their quality of life, but early treatment can help.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Higher cholesterol levels increase aggressive prostate cancer risk.